tirzepatide patient information for Medical Weight Loss Life-threatening condition' added to Mounjaro

Ultimately, this could help develop safer and more individualized dietary interventions

The technology we use is FDA-cleared and has a long-standing track record of helping people safely achieve their body contouring goals

Grasas (lpidos) 0g

The new weight-loss drugs have created a hope and optimism among my patients that I have frankly not seen before, says Sarah C

FDA approves Novo Nordisks oral semaglutide (Rybelsus) for CV risk reduction in T2DM adults owenhaskins Oct 20, 2025 3 min read Novo Nordisk has received FDA approval for Rybelsus for reducing the risk of major adverse cardiovascular events (MACE) such as cardiovascular (CV) death, heart attack, or stroke in adults with type 2 diabetes who are at high risk for these events, whether they've had a prior CV event or not (primary and secondary prevention)

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and diabetes drugs for cash-paying patients